Picture of China Biotech Services Holdings logo

8037 China Biotech Services Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for China Biotech Services Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-110203181863-142
Depreciation
Amortisation
Non-Cash Items36.5717.2-11.330.3
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital22.6172-225-435251
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-30.342240.5483195
Capital Expenditures-7.35-127-12.2-122-62.9
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-92.90.3524.09-135-4.65
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-100-126-8.12-256-67.5
Financing Cash Flow Items0.327-3.79-219-303-162
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities23.143.9-267-282-146
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-109339-234-57.8-20.7